Valneva SE (VLA)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

€2.816

Buy

€2.824

arrow-down€-0.004 (-0.14%)

Prices updated at 01 Apr 2026, 16:09 CEST

Prices minimum 15 mins delay

Prices in EUR

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes two vaccines for travelers; one for the prevention of Japanese encephalitis (IXIARO) and the second (DUKORAL) for the prevention of cholera and diarrhoea.

FTSE EuroFirst 300

2.39%

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Biotechnology

Chairman

Ms. Anne-Marie Graffin

CEO

Mr. Thomas Lingelbach

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

674

Head office

12 ter Quai Perrache

Lyon

France

69002

+33 478766101

investors.relations@vivalis.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. James R. Sulat Vice Chairman of the Board	0.11m
Mr. Gerd Zettlmeissl Director	0.03m
Mr. Thomas Lingelbach Director, President and Chief Executive Officer	0.58m
Mr. Peter Buhler Chief Financial Officer	0.20m
Ms. Anne-Marie Graffin Chairman of the Board	0.13m
Dr. Juan Carlos Jaramillo, M.D. Chief Medical Officer	0.20m
Ms. Daniele Guyot-Caparros Independent Director	0.07m
Ms. Dipal Patel Chief Commercial Officer	0.18m
Mr. James Connolly Independent Director	0.11m
Mr. Vincent Dequenne Chief Operating Officer	-
Ms. Petra Pesendorfer Chief People Officer	-
Dr. Kathrin Jansen, PhD Director	0.09m
Ms. Hanneke Schuitemaker Chief Scientific Officer	-
Ms. Kendra Wergin General Counsel and Corporate Secretary	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Candriam - Belgian Branch	2,397,561
Candriam Eqs L Biotechnology	2,397,561
BlackRock Fund Advisors	1,426,287
General American Investors Co Inc	1,152,180
General American Investors	1,152,180

Director dealings

Date chevron-l-regular chevron-r-regular	Action
No data

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.